BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Stolen Roche Cancer Drug Found On Market     4/17/2014   More...
Puma Biotechnology Plummets On Disappointing Breast Cancer Drug Results     4/9/2014   More...
Pfizer Inc. Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers     4/8/2014   More...
Curis, Inc. Announces Removal Of FDA Partial Clinical Hold On CUDC-427     3/31/2014   More...
Roche Wins Battle Over Launch Of Biosimilar Version Of Its Breast Cancer Drug Herceptin     2/7/2014   More...
Pfizer Inc.'s New Breast Cancer Treatment Succeeds In Phase 2 Trial     2/4/2014   More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.), Astellas Pharma Inc. Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer     1/30/2014   More...
BioCon Limited Hits Roche First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin     1/21/2014   More...
AbbVie Drug Shows Promise Against Difficult Type Of Breast Cancer     12/13/2013   More...
AstraZeneca PLC's Arimidex Halves Breast Cancer Risk, Study Finds     12/12/2013   More...
Puma Biotechnology Surges To New High On Positive Phase 2 Test Of Breast Cancer Drug; Stock Up +68.15% At Market Close (December 5, 2013)     12/6/2013   More...
Merrimack Pharmaceuticals Inc.'s MM-121 Demonstrates Positive Signal In Two Phase 2 Breast Cancer Studies; Stock Up +11.46% At Market Close (November 26, 2013)     11/26/2013   More...
Novartis AG Chases Pfizer Inc. In Hot New Breast Cancer Drug Area     11/25/2013   More...
Soricimed Biopharma, Inc. Shows Promise in Treating Breast and Ovarian Cancer     10/16/2013   More...
FDA Approves Genentech's First Pre-Surgical Breast Cancer Drug     10/2/2013   More...
 Featured Stories
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014   More...
Can Vitamin A Turn Back The Clock On Breast Cancer? Thomas Jefferson University Study     3/31/2014   More...
Breast Cancer Drug Fights Fungal Disease, University of Rochester Study     2/11/2014   More...
Melatonin May Slow Breast Cancer Tumor Growth, PLoS One Reveals     1/29/2014   More...
Peanuts Linked to Lower Breast Cancer Risk, Washington University School of Medicine Study     9/27/2013   More...
Protein Predicts Breast Cancer Prognosis, University of Illinois Study     8/30/2013   More...
Fish May Reduce Breast Cancer Risk, Zhejiang University Study     6/28/2013   More...
Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Duke Cancer Institute Study     6/18/2013   More...
A Cautionary Perspective on Angelina Jolie's Double Mastectomy     5/15/2013   More...
University of Texas MD Anderson Cancer Center Study Reveals Magnitude of Variation in Gene Expression Measurements Within Breast Cancers     5/3/2013   More...
Certain Breast Cancers Have a Trait That Could Be Attacked by New Therapies, University of Missouri Study     3/29/2013   More...
Manipulating Transcription Factor Can Change Subtype of Breast Cancer, Garvan Institute of Medical Research Study     1/2/2013   More...
Ability to Metabolize Tamoxifen Affects Breast Cancer Outcomes, Mayo Clinic Study     12/27/2012   More...
Vanderbilt University Medical Center Study Finds Diverse Genetic Alterations in Triple-Negative Breast Cancers     12/10/2012   More...
Periods Clue to Breast Cancer Onset, University of Oxford Study     10/18/2012   More...
 More News
Georgia's $14 Million Bioscience Training Center an Offshoot of Baxter International, Inc. (BAX)'s $1 Billion Plant, An Industrial Info News Alert     4/17/2014   More...
GlycoMimetics, Inc. (GLYC) Presents Data On Its E-Selectin Antagonist At American Association for Cancer Research Annual Meeting 2014     4/10/2014   More...
Nektar Therapeutics (CA) (NKTR) Reports Positive Preclinical Data For Two Oncology Programs At 2014 American Association for Cancer Research     4/9/2014   More...
Eli Lilly and Company (LLY) To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At American Association for Cancer Research 2014     4/7/2014   More...
Basilea Pharmaceutica (BSLN.SW)'s Oncology Drug Candidate BAL101553 Demonstrates Broad Antitumor Activity In Treatment-Resistant Breast Cancer Models As Presented At American Association for Cancer Research     4/7/2014   More...
Sorrento Therapeutics, Inc. Announces Key Presentation On Cynviloq At The American Association for Cancer Research Annual Meeting     4/4/2014   More...
Hologic, Inc. (HOLX) To Showcase Total 3D Mammography (Tomosynthesis) Solution At National Consortium Of Breast Centers (NCoBC) Annual Conference     3/14/2014   More...
Roche (RHHBY) And Jiangsu Province Bring Down High Cost Of Breast Cancer Drug     3/13/2014   More...
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial In HER2/Neu+ Breast Cancer     3/3/2014   More...
Eisai Inc. (ESALF.PK) Announces Initiation Of A Phase 3 Trial Of Eribulin Mesylate Injection Versus Weekly Paclitaxel In First And Second Lines Of Metastatic Breast Cancer     2/27/2014   More...
Oncothyreon Inc. (ONTY) And Array BioPharma, Inc. (ARRY) Announce Initiation Of Phase 1b Trial Of ONT-380 In Combination With TDM-1 In Patients With Metastatic HER2+ Breast Cancer     2/20/2014   More...
Syndax Pharmaceuticals Inc. Announces National Cancer Institute And FDA Reach Agreement On A Special Protocol Assessment (SPA) For The Phase 3 Trial Of Entinostat In Patients With Advanced ER+ Breast Cancer     2/13/2014   More...
Generex Biotechnology Corporation (GNBT) Provides Update On Antigen Express Phase II AE37 Breast Cancer Vaccine Trial     2/12/2014   More...
Oncothyreon Inc. (ONTY) And Array BioPharma, Inc. (ARRY) Announce Initiation Of Phase 1b Trial Of ONT-380 In Combination With Capecitabine And/Or Trastuzumab In Patients With Metastatic HER2+ Breast Cancer     2/3/2014   More...
Nektar Therapeutics (CA) (NKTR) Release: Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis For BEACON Pivotal Phase 3 Clinical Study In Patients With Metastatic Breast Cancer     1/14/2014   More...